Shane O’Neill

has 35 years of experience in the clinical diagnostics industry. He is currently the Global Director of Scientific Affairs, EKF Diagnostics. He is a keen advocate of new technologies and chemistries that bring new insights into patient care, particularly those associated with diabetes such as glycated albumin and beta-hydroxybutyrate.